Ergoloid Mesylates (Dihydrogenated Ergot Alkaloids; Dihydroergotoxine)

A to Z Drug Facts

Ergoloid Mesylates (Dihydrogenated Ergot Alkaloids; Dihydroergotoxine)

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(err-GO-loyd- MEH-suh-lates)
Gerimal, Hydergine, Hydergine LC, Niloric
Class: Psychotherapeutic

 Action Unknown; may increase brain metabolism, possibly increasing cerebral blood flow.

 Indications Treatment of age-related decline in mental capacity, primary progressive dementia, Alzheimer's dementia, multi-infarct dementia and senile onset.

 Contraindications Hypersensitivity to ergoloid mesylates or other ergot alkaloids; acute or chronic psychosis.

 Route/Dosage

ADULTS: PO/SL 1 to 2 mg tid (up to 12 mg/day has been used).

 Interactions None well documented.

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: Orthostatic hypotension; bradycardia. DERM: Rash. GI: Transient nausea; GI disturbances; sublingual irritation.

 Precautions

Pregnancy: Pregnancy category undetermined. Lactation: Undetermined. Children: Safety and efficacy not established. Special risk patients: Administer drug with caution to patients with history of bradycardia or hypotension. Liver impairment: Elimination of drug may be affected.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

OVERDOSAGE: SIGNS & SYMPTOMS
  Headache, flushing, anorexia, nausea, vomiting, abdominal cramps, nasal congestion, impaired vision, dizziness, fainting

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts